{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:27Z","timestamp":1786998447189,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ygyno.2013.01.018","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T21:17:21Z","timestamp":1359235041000},"page":"377-383","source":"Crossref","is-referenced-by-count":48,"title":["A comparison between an ultrasound based prediction model (LR2) and the Risk of Ovarian Malignancy Algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass"],"prefix":"10.1016","volume":"129","author":[{"given":"Jeroen","family":"Kaijser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Van Gorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Van Hoorde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Van Holsbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Sayasneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Van Calster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.01.018_bb0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(06)70579-4","article-title":"Proteins with whey-acidic-protein motifs and cancer","volume":"7","author":"Bouchard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissue","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0015","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/sj.onc.1205363","article-title":"The putative ovarian tumour marker gene HE4 (WFCD2) is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms","volume":"21","author":"Bingle","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0020","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0030","first-page":"3695","article-title":"The HE4 (WFCD2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ygyno.2013.01.018_bb0035","doi-asserted-by":"crossref","first-page":"351.e1","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ygyno.2010.02.005","article-title":"Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass","volume":"117","author":"Nolen","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"2 part 1","key":"10.1016\/j.ygyno.2013.01.018_bb0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/AOG.0b013e318224fce2","article-title":"Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass","volume":"118","author":"Moore","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0055","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-11-0635","article-title":"Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management","volume":"20","author":"Bandiera","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1515\/CCLM.2011.085","article-title":"Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case\u2013control study in a Korean population","volume":"49","author":"Kim","year":"2011","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"10.1016\/j.ygyno.2013.01.018_bb0065","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1515\/CCLM.2011.709","article-title":"The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses","volume":"49","author":"Lenhard","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0070","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","article-title":"HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ygyno.2013.01.018_bb0075","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.cca.2011.04.028","article-title":"HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm","volume":"412","author":"Ruggeri","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.ygyno.2013.01.018_bb0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.018_bb0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/CCLM.2011.075","article-title":"The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?","volume":"49","author":"Montagnana","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0095","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.2006.09.5943","article-title":"Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors","volume":"25","author":"Timmerman","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0100","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/jnci\/djm199","article-title":"Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125","volume":"99","author":"Van Calster","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/uog.6415","article-title":"Adding a single CA-125 measurement to ultrasound performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses","volume":"34","author":"Valentin","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.018_bb0110","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/1078-0432.CCR-11-0879","article-title":"External validation of diagnostic models to estimate the risk of malignancy in adnexal masses","volume":"18","author":"Van Holsbeke","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/uog.11088","article-title":"A prospective evaluation of the IOTA Logistic Regression Model (LR2) for the diagnosis of ovarian cancer [published online ahead of print January 5, 2012]","author":"Nunes","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0120","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1469-0705.2000.00287.x","article-title":"Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group","volume":"16","author":"Timmerman","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0125","series-title":"World Health Organization classification of tumours. Pathology and genetics of the breast and female genital organs","year":"2003"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0130","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2013.01.018_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1525-1438.2006.00319.x","article-title":"Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals","volume":"16","author":"Paulsen","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0145","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/1078-0432.CCR-08-0113","article-title":"Prospective internal validation of mathematical models to predict malignancy in adnexal masses: results from the international ovarian tumor analysis study","volume":"15","author":"Van Holsbeke","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.018_bb0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/uog.7636","article-title":"Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group","volume":"36","author":"Timmerman","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0155","doi-asserted-by":"crossref","first-page":"228e1","DOI":"10.1016\/j.ajog.2010.03.043","article-title":"Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass","volume":"203","author":"Moore","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.018_bb0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2013.01.018_bb0165","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.282.11.1061","article-title":"Empirical evidence of design-related bias in studies of diagnostic tests","volume":"11","author":"Lijmer","year":"1999","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ygyno.2013.01.018_bb0170","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/uog.11177","article-title":"Clinically oriented three-step strategy for assessment of adnexal pathology","volume":"40","author":"Ameye","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ygyno.2013.01.018_bb0175","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.ejca.2011.12.003","article-title":"Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses","volume":"48","author":"Van Gorp","year":"2012","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2013.01.018_bb0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1469-0705.1999.13010011.x","article-title":"Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience","volume":"13","author":"Timmerman","year":"1999","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ygyno.2013.01.018_bb0185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.0960-7692.2001.00500.x","article-title":"Comparison of \u2018pattern recognition\u2019 and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation","volume":"18","author":"Valentin","year":"2001","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T19:02:53Z","timestamp":1562612573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0090825813000280"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.01.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}